The secure way to view our meeting materials, annual documents, and to vote your shares.
View an enhanced version of the report summarizing our financial and operational performance for the year 2022.
View the enhanced document outlining key information about the upcoming shareholder meeting.
Your vote is important. You may vote online or by phone.
To vote by phone, dial 866-217-7017.
June 9, 2023
9:00 a.m. Mountain Time
Deadline to Register:
June 7, 2023
5:00 p.m. Eastern Time
Note: You must register by the deadline to be eligible to participate in the meeting.
NuVasive, Inc. (NASDAQ: NUVA) is the leader in spine technology innovation, with a mission to transform surgery, advance care, and change lives. The Company's less-invasive, procedurally integrated surgical solutions are designed to deliver reproducible and clinically proven outcomes. The Company's comprehensive procedural portfolio includes surgical access instruments, spinal implants, fixation systems, biologics, software for surgical planning, navigation and imaging solutions, magnetically adjustable implant systems for spine and orthopedics, and intraoperative neuromonitoring technology and service offerings. With more than $1 billion in net sales, NuVasive operates in more than 50 countries serving surgeons, hospitals, and patients. For more information, please visit nuvasive.com.